Cargando…
Effects of testosterone replacement on serotonin levels in the prostate and plasma in a murine model of hypogonadism
Benign prostate hyperplasia is a dysfunctional disease with an elevated prevalence. Despite the accepted impact of aging and testosterone (TES) in its pathophysiology, its aetiology remains unknown. Recent studies described that serotonin (5-HT) inhibits benign prostate growth through the modulation...
Autores principales: | Mota, Paulo, Barbosa-Martins, João, Moura, Rute S., Lima, Estêvão, Miranda, Alice, Correia-Pinto, Jorge, Carvalho-Dias, Emanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477238/ https://www.ncbi.nlm.nih.gov/pubmed/32895458 http://dx.doi.org/10.1038/s41598-020-71718-z |
Ejemplares similares
-
Serotonin regulates prostate growth through androgen receptor modulation
por: Carvalho-Dias, Emanuel, et al.
Publicado: (2017) -
Testosterone replacement in male hypogonadism
por: Kalra, Sanjay, et al.
Publicado: (2010) -
Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014) -
Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
por: Davidiuk, Andrew J., et al.
Publicado: (2016) -
The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
por: Shin, Yu Seob, et al.
Publicado: (2019)